(Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, will participate in a live investor webinar, “Advancing Inflammatory Disease Treatment: Insights & ...

Notably, 2 deaths occurred in the iscalimab group, 1 due to urosepsis and another associated with macrophage-activation syndrome. Opportunistic infections, including tuberculosis and herpes zoster, ...

Inflammation is a vital part of the immune response, but it seems that the system can sometimes go awry, resulting in chronic inflammation that has been linked to conditions such as cancer ...

This article explores innovative drug delivery strategies, including DNA barcoding, shape-engineered nanoparticles and biomimetic nanovesicles, highlighting their role in improving precision medicine ...

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...

MOST health experts would agree that you don’t have to take supplements to maintain good health. But for certain people, ...

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

Certain herbs like ginseng and echinacea can fight microorganisms like viruses, bacteria, worms, and bugs. Here's how to use ...

Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...

Discover which foods and strategies actually boost iron status and why the right dose and pairing can make the difference ...

FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA ...